Company news

Theravance Biopharma, Inc. news in 2023

Theravance Biopharma, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors

December 20, 2023

Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference

December 17, 2023

Theravance Biopharma to Present New Ampreloxetine Data at the 34th International Symposium on The Autonomic Nervous System

November 15, 2023

Theravance Biopharma to Participate in the 6th Annual Evercore ISI HealthCONx Conference

November 14, 2023

Viatris and Theravance Biopharma Announce Positive Top-Line Results from YUPELRI® (revefenacin) Phase III Trial in China for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)

November 12, 2023

Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

November 6, 2023

Theravance Biopharma to Report Third Quarter 2023 Financial Results on November 7, 2023

October 18, 2023

Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders

August 27, 2023

Theravance Biopharma, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update

August 6, 2023

Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023

July 23, 2023

Theravance Biopharma, Inc. Announces Orphan Drug Designation Granted to Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

May 8, 2023

Theravance Biopharma, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update

May 7, 2023

Theravance Biopharma to Report First Quarter 2023 Financial Results on May 8, 2023

April 23, 2023

Theravance Biopharma, Inc. Announces Appointment of Jim Kelly, Managing Director at Weiss Asset Management, to Board of Directors

April 10, 2023

Theravance Biopharma, Inc. Announces Strategic Actions and Reports Fourth Quarter / Full Year 2022 Financial Results and Business Update

February 26, 2023

Theravance Biopharma to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023

February 20, 2023

Theravance Biopharma, Inc. Highlights 2022 Accomplishments and 2023 Key Targets

January 8, 2023

Calls in 2023

Decks in 2023